Clinical Trials Logo
  1. Home
  2. Female Contraception
  3. NCT03432416

Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring

Female Contraception Clinical Trial

Official title:
A Multicenter, Open-label Randomized Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of Nestorone® and Estradiol (NES-E2 CVR).

Clinical Trial Summary

This will be a multi-site, open-label, randomized clinical trial. The investigators will randomize 300 eligible participants in a 1:1 ratio to two different treatment regimens that are to be followed when using a contraceptive vaginal ring delivering a daily dose of Nestorone® and estradiol (NES-E2 CVR).

Clinical Trial Description

The total duration of the study for each participant is expected to be approximately 13.5-15.5 months: including screening and enrollment (up to 8 weeks), 12 months of participation, and a post-removal follow up period removal of at least 17 days. After enrollment, subject visits occur at day 31, 92, 183, 274, and 364 with telephone calls at day 60, 120, 150, 210, 240, 300, and 330. Subjects will use a home pregnancy test 17 days post-removal of the ring and will call the site report the result and for safety follow-up. Another phone call will be required after that if the subject chooses not to being a hormonal contraceptive; this call will occur at the time of the subject's first spontaneous menses.

Subject recruitment is expected to begin Q1 (in the first quarter of) 2018 and is planned to continue through Q1 2019. However, if the enrollment rate declines, the enrollment period may be extended beyond this date. If this enrollment timeline is met, all subjects should finish active treatment by approximately the end of Q1 2020. The end of the study will occur when the last subject to be enrolled has completed her post-removal telephone call(s).

Preliminary results of the study are expected to be available Q3 of 2020 based on the current study plan. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03432416
Study type Interventional
Source Health Decisions
Contact Emily Korhonen
Phone 919-967-1111
Email ekorhonen@healthdec.com
Status Recruiting
Phase Phase 2
Start date February 12, 2018
Completion date June 20, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT02575209 - Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects N/A
Active, not recruiting NCT03124160 - Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard Phase 3
Completed NCT01879891 - Exercise Intensity, Metabolic Rate and Insulin Sensitivity N/A
Not yet recruiting NCT06395064 - The Effect of Dimenhydrinate on Postoperative Nausea and Vomiting After Abdominal Hysterectomy: Randomized-controlled Trial N/A
Completed NCT02720783 - Tolerability and Pharmacokinetic Study of Econazole Nitrate Plus Benzydamine HCl Vaginal Pessary Phase 1
Recruiting NCT04143659 - A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception Phase 1
Completed NCT01764412 - Study of Serum Hepcidin Rate Variations During Menstrual Cycle N/A
Completed NCT05777252 - Effects of 16-Week Circuit Training in Healthy Women N/A
Completed NCT05777265 - The Effects of 16-Week Circuit Training in Healthy Women N/A
Completed NCT03147703 - Timing of Food Intake Impacts Daily Rhythms of Human Saliva Microbiota N/A
Recruiting NCT05994599 - Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring Phase 1
Not yet recruiting NCT03961412 - A Family-based Intervention to Improve Pap Test Screening Among Under-screened Chinese American Immigrant Women Early Phase 1
Completed NCT02908503 - Vaginal Film Administration and Placement Study: FLAG N/A
Completed NCT01293591 - Garlic Intake And Biomarkers Of Cancer Risk N/A
Completed NCT02268032 - Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve Phase 1
Completed NCT02994602 - Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males Phase 1
Completed NCT04189796 - Jarlsberg Cheese Compared to Camembert Cheese N/A
Unknown status NCT01809405 - Validation of Sexual Function Scale in Female Cancer N/A
Completed NCT03412617 - Diets, Metabolic Profile and Gut Microbiota Among Indonesian Women in Minangkabau and Sundanese-ethnic Community N/A
Completed NCT02112903 - Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women Phase 1